Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04759755 · ClinicalTrials.gov registry record

Circadian Timing, Information Processing and Energy Balance Study

A clinical trial of Overweight and Obesity, sponsored by University of Utah.

Completed
Registry status
139
Enrollment target
1
Study location

NCT04759755: Completed study of Overweight and Obesity, sponsored by University of Utah.

NCT04759755 is a study of Overweight and Obesity that has completed, run by University of Utah. The registered enrollment target is 139 participants, below the 227-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04759755, a study of Overweight and Obesity, has completed, sponsored by University of Utah.

COMPLETED
Registry status
139 participants
Enrollment target
1
Study location

Study Summary

This study design will test biological and behavioral mechanisms in the cross-sectional analyses and determine the prospective effects of circadian alignment and sleep on changes in cardiometabolic risk factors.

Primary Outcome

Measured by a frequently sampled IV glucose tolerance test

Conditions Studied

Study Locations (1)

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 139 participants
Start Date 2019-05-29
Est. Completion 2024-05-31
University of Utah

818 total trials

What the finished NCT04759755 record still lists

NCT04759755 is an observational study that tracks outcomes without assigning an intervention. The registered 139 participants enrollment target is mid-sized for trials with a published cap, below the 227-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (39% lower).

The record links to 1 condition, with Overweight and Obesity appearing as the primary indexed condition, and to 0 interventions.

NCT04759755 reports a single indexed study location in Utah.

Frequently Asked Questions

What is clinical trial NCT04759755 about?

NCT04759755 is a clinical study titled "Circadian Timing, Information Processing and Energy Balance Study". This study design will test biological and behavioral mechanisms in the cross-sectional analyses and determine the prospective effects of circadian alignment and sleep on changes in cardiometabolic risk factors.

What is the current status of trial NCT04759755?

This trial is currently completed. The enrollment target is 139 participants. The study started on 2019-05-29. Estimated completion is 2024-05-31.

What conditions does trial NCT04759755 study?

This clinical trial studies the following conditions: Overweight and Obesity.

Who is sponsoring clinical trial NCT04759755?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04759755 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight and Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04759755's enrollment target sits among peer trials

139 46th of 115 higher than 69 of 115 other Overweight and Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Overweight and Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05645380 · 139 participants · Phase 2

    Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC

  • NCT06239272 · 139 participants · Phase 1

    NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

  • NCT06252220 · 139 participants · Phase 1

    First in Human Study in Subjects With Obesity, But Otherwise Healthy

  • NCT06537128 · 139 participants · NA

    Internet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and Anxiety

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04759755, the US trial registry maintained by the National Library of Medicine. NCT04759755 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.